Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Chun

Showing results (731-740 of 947) with videos related to

Pageof 95
Sort By:
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Genitourinary Cancer|May 26, 2022
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer PatientsFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
World Journal of Urology|December 1, 2012
Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladderLuis A Kluth, Harun Fajkovic, Evanguelos Xylinas, et al.
European Urology Focus|October 4, 2024
Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary BladderMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
Molecular Cell|June 30, 2015
Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 SubstratesDaniel F Egan, Matthew G H Chun, Mitchell Vamos, et al.
The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Annals of Surgical Oncology|February 27, 2026
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Pageof 95

Showing results (731-740 of 947) with videos related to

Sort By:
Pageof 95
International Urology and Nephrology|November 19, 2021
Survival after radical prostatectomy vs. radiation therapy in ductal carcinoma of the prostateFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
Clinical Genitourinary Cancer|May 26, 2022
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer PatientsFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
BJU International|October 13, 2006
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patientsFelix K-H Chun, Alberto Briganti, Elie Antebi, et al.
World Journal of Urology|December 1, 2012
Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladderLuis A Kluth, Harun Fajkovic, Evanguelos Xylinas, et al.
European Urology Focus|October 4, 2024
Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary BladderMario de Angelis, Carolin Siech, Francesco Di Bello, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
BJU International|September 16, 2009
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancerHendrik Isbarn, Pierre I Karakiewicz, Sascha A Ahyai, et al.
Molecular Cell|June 30, 2015
Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 SubstratesDaniel F Egan, Matthew G H Chun, Mitchell Vamos, et al.
The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
Annals of Surgical Oncology|February 27, 2026
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
Pageof 95